Skip to search formSkip to main contentSkip to account menu

LM 5008

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

indalpine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Further studies on the mechanism of serotonin-dependent anorexia in rats
Abstract4-(3-Indolyl-2-ethyl)piperidine (LM 5008), 2-(1-piperazinyl) quinoline (quipazine), and metachlorophenylpiperazine (mCPP… 
1984
1984
PRESENCE OF CHOLINOCEPTORS IN MESENCEPHALIC RAPHE NUCLEI CONCERNED IN THERMOREGULATION IN RABBITS
1. The thermal effects of cholinomimetics and cholinoceptor blocking agents microinjected into mesencephalic nucleus raphe… 
1984
1984
The analgesic efficacy of a serotonin reiftake blocker, zimelidine, in the treatment of chronic benign pain
1984
1984
Possible tryptaminergic involvement in the modulation of pain and of endogenous opiate activity in man
1983
1983
Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5‐hydroxytryptamine uptake blocker
1 The administration of 4‐[2‐(3‐indolyl)ethyl]piperidine (LM 5008), a selective 5‐hydroxytryptamine (5‐HT) uptake blocker to rats… 
1983
1983
Effects of LM 5008, a selective inhibitor of 5‐hydroxytryptamine uptake, on blood pressure and responses to sympathomimetic amines
1 LM 5008 (4‐[2‐(3‐indolyl)ethyl]piperidine) (10, 20 and 50 mg kg−1) had no significant effect on pressor responses to… 
1981
1981
Clinical pharmacological studies with LM 5008, a new antidepressant.
A spectrofluorometric assay has been developed for the measurement of LM 5008, a novel antidepressant, in biological fluids. A… 
1978
1978
Plasma free 5-hydroxytryptamine (5-HT): evidence of an increase induced by LM 5008, a potent 5-HT uptake inhibitor.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)